Company Announcements

Directorate Change

Source: RNS
RNS Number : 5459X
20 December 2019

20 December 2019



EMIS Group plc ("EMIS Group" or the "Company")


Directorate change


EMIS Group, the UK leader in connected healthcare software and services, today announces the planned retirement of Mike O'Leary and is pleased to announce the appointment of Patrick De Smedt to the Board as an independent Non-executive Director and Chairman designate.


Mike will retire at the conclusion of the 2020 Annual General Meeting (AGM) on 6 May 2020, after nine years of service with EMIS Group as Chairman of the Board and of its nomination committee.


Patrick De Smedt will be formally appointed as an independent Non-executive Director on 1 January 2020 and will take over as Chairman of the Board and of its nomination committee on Mike's retirement.


Patrick has a wealth of international business experience including a diverse portfolio of Board appointments in public and private equity-backed companies varying in size up to multi-billion pound revenues. He was previously interim Chairman of KCOM Group plc during a period which included the successful sale of the company earlier this year. His entire executive career was spent in the software sector, primarily with Microsoft, across a range of management roles throughout Europe. His last executive role was as Chairman for Microsoft EMEA.  He is currently Senior Independent Director of PageGroup plc, in addition to a number of private company roles.



Commenting on the appointment, Mike O'Leary, Chairman of EMIS Group, said:


"I am extremely pleased that Patrick has agreed to join our Board and to succeed me as Chairman.  Patrick has a wealth of experience of the UK and global technology sector as well as of public company governance, which makes him eminently well-qualified to help the executive team take EMIS to the next level."


The following information is disclosed in accordance with Schedule 2(g) of the AIM Rules for Companies:

Full name:   Patrick Jean-Marie De Smedt


Age: 64


Current Directorships:


Divitias HoldCo Ltd appointed 15 May 2018

PageGroup plc appointed 1 August 2015

Kodak Alaris Holdings Ltd appointed 1 June 2014

The Chancellery Residents Company Ltd appointed 24 November 2009

18 St. James Management Company Ltd appointed 4 November 2009

Directorships held in the past five years:


Nexinto Holding Ltd (4 December 2013 - 30 November 2017)
Victrex Plc (28 July 2008 - 9 February 2018)
Morgan Sindall Group Plc (1 December 2009 - 31 December 2018)
KCOM Group Plc (28 January 2016 - 1 August 2019)

Anite plc (26 September 2013 - 13 August 2015)

There are no further disclosures to be made in connection with Schedule Two of paragraph (g) of the AIM rules for companies in connection with this appointment.


- ENDS -


For further information, contact:


EMIS Group plc                                                                                Tel: 0113 380 3000

Andy Thorburn, CEO

Peter Southby, CFO


Numis Securities Limited (nominated adviser and broker)         Tel: 020 7260 1000

Oliver Hardy/Simon Willis/James Black


MHP Communications                                                                     Tel: 020 3128 8572

Reg Hoare/Giles Robinson/Patrick Hanrahan/Florence Mayo


Information for investors, including analyst consensus forecasts, can be found on the Group's website at


Notes to editors


EMIS Group is the UK leader in connected healthcare software and systems. Its solutions are widely used across every major UK healthcare setting. EMIS Group's aim is to join up healthcare through innovative technology, helping to deliver better health outcomes to the UK population, supporting longer and healthier lives.


EMIS Group has two core business segments: EMIS Health and EMIS Enterprise.


EMIS Health is a supplier of innovative integrated care technology to the NHS, including primary, community, acute and social care.


EMIS Enterprise is focussed on growth in the business-to-business technology sector within the healthcare market, including management of medicines, partner businesses, patient-facing services and UK healthcare blockchain.


EMIS Group's brands include:


•     EMIS Health, supplying innovative and essential technology to 10,000 healthcare users, in the number one or number two market positions in each of its major markets;

•     Patient, the UK's leading independent provider of patient-centric medical and wellbeing information and related transactional services;

•     Egton, providing specialist ICT infrastructure, hardware and engineering services and non-clinical software into health and social care; and

•     Dovetail Lab, a health technology company developing blockchain software to facilitate the integration of healthcare data.



This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit